Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium Bromide + Salbutamol for Acute Asthma in Children
NCT02235428Phase 4Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Sep 1998
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Ipratropium bromide + Salbutamol with Salbutamol + Placebo (2 arms). Primary endpoint: Changes from baseline in pulmonary resistance (Rint). Started Sep 1998; status: terminated.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02235428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235428.